Finally, through an integrated transcriptomic approach validated in tumor tissues, we define the molecular mechanism of action and translational impact of successful CDX2 reinstatement via PRKAB1 agonism (see Figure 1-Step 4). Here, CDX2 is linked to neoplasm.